To evaluate the incidence of overall and cause-specific mortality among consecutive patients aged 18 and older presenting with hip fracture to the Juravinski Hospital of the Hamilton Health Sciences.

This pilot study assessed the feasibility of a larger prospective international cohort study. After eligibility had been confirmed and informed consent obtained, participants were registered in the study.

Troponin level, complete blood counts and serum creatinine level were collected at day 1 through day 10 post admission. CAM instrument was employed at admission and once daily post admission day 1 through day 10. FIM Instrument was administered within 72 hours of admission to establish pre-fracture functional independence and disability. Patients were contacted by research personnel by telephone 30 days after study registration.

Primary endpoints:

  • Feasibility
  • Total and cause-specific mortality

The co-Principal Investigator of the HIP VISION Pilot study was Mohit Bhandari.

Study Type


Study Design

Cohort evaluation

NO. of Countries


NO. of Sites


NO. of Participants


Study Period

2013 - 2014



Hamilton Health Sciences

Back To Top